Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Anbogen, Astrazeneca, Atea, ATMA Journey Centers, Belite, Biontech, Cstone, Gilead Sciences, H. Lundbeck, I-Mab, Innocare, Novavax, Otsuka, Pfizer, Revive, Takeda, Transcenta, Vaxxinity.